Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AIM: Direct‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs)....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Clin Pharmacol
Asıl Yazarlar: Stolk, Leo M., de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, ten Cate‐Hoek, Arina, Burden, Andrea M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Pharmacoepidemiology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495191/
https://ncbi.nlm.nih.gov/pubmed/28326589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13264
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller